Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Use Unpledged assets...

    Use Unpledged assets of Singh brothers to repay Daiichi's award: HC

    Written by Ruby Khatun Khatun Published On 27 Feb 2018 4:47 AM  |  Updated On 27 Feb 2018 4:47 AM
    Use Unpledged assets of Singh brothers to repay Daiichis award: HC

    New Delhi: The Delhi High Court in its interim order has issued a warrant to attach the unpledged assets of RHC Holding Pvt Ltd and Oscar Investments Ltd that is controlled by Singh brothers to enable Daiichi Sankyo to recover Rs 3500 crore international arbitration award from them.


    The unpledged assets include shares, moveable and immovable property, art as well as debts owed to Oscar Investments and RHC Holding.


    The decision comes after a petition was filed by Daiichi seeking implementation of the 31 January order of the court upholding the enforceability of the Rs3500 crore arbitral award passed against Singh brothers.


    The court has also directed the two companies not to operate their bank accounts, except for paying salaries and making statutory payments.


    The court has also passed a 'Garnishee Order' so that any debts owed to the two companies could be directed towards paying the award reports ET.


    The court had further directed the Singh brothers and others, to submit an up-to-date affidavit declaring all the unpledged assets held by them by the next hearing on March 23.

    However, the court order directing Singh brothers and others to maintain status-quo with respect to the remaining unattached assets held by them, directly or indirectly, would continue till the next hearing.


    On 31 January, the Delhi High Court had upheld an international arbitral award of Rs 3500 crore passed in favor of Japanese pharma major Daiichi Sankyo, which had alleged that the former promoters of Ranbaxy Laboratories had concealed information about proceedings against them while it was bought by Daiichi in 2008.


    Read also: Rs 3,500 crore jolt to Singh brothers as Delhi High Court upholds the arbitral award
    Daiichi SankyoDelhi high courtHigh Courtinternational arbitration awardOscar Investments LtdRanbaxy laboratoriesRHC Holding Pvt LtdSingh brothersUnpledged assets

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok